Able Innovations Introduces Novel Robotic Patient Transfer Technology Across Canada

H2i venture Able Innovations recently announced coast-to-coast partnerships for the implementation and evaluation of their novel robotic patient transfer technology.

The venture is the world’s first provider of automated patient transfer technology. Their flagship product, the ALTA platform, is poised to have a significant, multifaceted impact on the healthcare system. The current standard for patient transfers involves up to eight frontline health workers and causes frequent injuries. The automation provided by the ALTA platform, powered by physical AI, allows healthcare institutions to both prevent workplace strain and injury among their staff, and provide a more dignified patient experience. Further, given the current estimated cost of workplace injury for healthcare workers is upwards of $20 billion, innovation devices like the ALTA platform can facilitate crucial savings for the Canadian healthcare system.

In the recent announcement, Able Innovations shared that they have partnered with five major hospitals from coast-to-coast to implement and evaluate their novel device. The news is gaining broad media attraction, with coverage from CBC News, CBC Listen Ottawa, CTV Ottawa, TechBeat Canada, and Robotics Business News.

Able Innovations first joined H2i in 2018. The venture is led by co-founders Jayiesh Singh, CEO, and Philip Chang, CTO, both U of T mechanical engineering alumni. The pair were driven to start the company by personal experiences with the current challenges presented by patient transfer. They have since grown their team, bringing together multidisciplinary experts with the shared goal of advancing the quality of care, efficiency and safety in healthcare.

Read the full press release here!